Subscribe

Health Tech Daily Brief - October 2, 2026

The day in healthcare technology: 21 stories across AI, telehealth, policy, funding, and more - curated October 2, 2026.

Health Tech Daily Brief - October 2, 2026

From the newsroom wire: 203 fresh stories shaping healthcare technology today. The full rundown, category by category.

AI in Healthcare

Africa Must Build Intelligent Health Infrastructure Before AI Implementation– Salako

nannews.ng2026-10-02

Comment: How AI and rising trial success rates are changing the outlook for investors

Healthcare Today2026-10-02

What turns an AI pathology tool into a companion diagnostic?

Drug Discovery News2026-10-02

Telehealth & Virtual Care

The role of technology in healthcare: a new direction for Pakistan

thenews.pk2026-10-02

AP govt set to launch Sanjeevani telemedicine in state on Jan 1

The New Indian Express2026-10-02

Broadband gaps leave rural communities facing multiple barriers to care

Healthcare IT News2026-10-02

Wearables & Remote Monitoring

The biowearable that helped one man find confidence managing diabetes

WBOC TV2026-10-01

Oura postpones IPO amid market uncertainty

MobiHealthNews2026-10-01

Noise REP Band review: Reliable tracking without the distraction of a screen

The Times of India2026-10-01

Health IT & Security

AMA: PBM Market Concentration Is On the Rise

The AMA found that OptumRx, Express Scripts, CVS Caremark and Prime Therapeutics controlled 75% of the national PBM market in 2024. The post AMA: PBM Market Concentration Is On the Rise appeared first on MedCity News.

medcitynews.com2026-10-01

Buchalter Data Breach Exposed Calif. Hospital Patient Data

Law3602026-10-01

Sanofi Puts Up $1B to Expand Regeneron Alliance and Develop Next-Gen Dupixent

Sanofi and Regeneron Pharmaceuticals will collaborate on four next-generation antibody drugs that could offer advantages over Dupixent, the blockbuster immunology drug spawned by their R&D alliance. The companies project these drugs will start reaching pivotal testing in 2029 — important because Dupixent faces patent expiration in 2031. The post Sanofi Puts Up $1B to Expand Regeneron Alliance…

medcitynews.com2026-10-01

Policy & Regulation

Health law programs expand clinics, research and student opportunities

National Jurist2026-10-02

Judge Bars HHS Medicaid Cuts For Wash. Noncitizens On SSI

Law3602026-10-02

Food Supplements Market Forecast to 2035: Aging Population and Preventive Health Drive Expansion

IndexBox2026-10-01

Funding & Deals

👨🏿‍🚀TechCabal Daily – Meta’s ad-verse ruling

TechCabal2026-10-02

M&A: Grindr Acquires PurposeMed for $250M to Build Full-Stack “Grindr Health” Telehealth Rail

What You Should Know Social networking platform Grindr Inc. announced an agreement to acquire PurposeMed Inc., the parent company of virtual HIV-prevention platform Freddie, for an upfront base purchase price of $250M ($190M in cash and $60M in Grindr common stock), with up to $70M in additional performance-based cash earnouts tied to fiscal year 2027 ... Read More

hitconsultant.net2026-10-01

Tiny Health Secures $33M to Scale Microbiome Intelligence Platform Across Lifespan

HIT Consultant2026-10-01

Digital Therapeutics

Podcast: Psychedelic-Assisted Therapy for Mental Health

psychcentral.com2026-10-01

FDA Clears DreaMed MODI: First CGM-Driven Insulin Dose Optimization App for Type 2 Injection Therapy

HIT Consultant2026-09-30

Mental Health Tech

Governor Newsom Allows Dangerous Chatbots to Provide Therapy

EIN News2026-10-02
Reach the people behind these stories. HealthTech Cube demand gen programs deliver qualified healthcare technology leads from $49.50 per lead - see packages or download the 2026 media kit.